Gland Pharma posts Rs. 285.90 crores consolidated PAT in Q4 FY2021-22

Gland Pharma Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 1168.248 crores during the period ended March 31, 2022 as compared to Rs. 1108.994 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 285.902 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 273.029 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 17.36 for the period ended March 31, 2022 as compared to Rs. 16.62 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 1168.248 crs	₹1108.994 crs	5.34%
Net Profit	₹285.902 crs	₹273.029 crs	4.71%
EPS	₹17.36	₹16.62	4.45%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 1168.248 crores during the period ended March 31, 2022 as compared to Rs.934.962 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.285.902 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.260.409 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.17.36 for the period ended March 31, 2022 as compared to Rs.15.88 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 1168.248 crs	₹934.962 crs	24.95%
Net Profit	₹285.902 crs	₹260.409 crs	9.79%
EPS	₹17.36	₹15.88	9.32%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.4624.646 crores during the Financial Year ended March 31, 2022 as compared to Rs.3597.652 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.1211.664 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.996.963 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.73.64 for the Financial Year ended March 31, 2022 as compared to Rs.62.99 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹4624.646 crs	₹3597.652 crs	28.55%
Net Profit	₹1211.664 crs	₹996.963 crs	21.54%
EPS	₹73.64	₹62.99	16.91%

Shares of Gland Pharma Limited was last trading in BSE at Rs. 3105.10 as compared to the previous close of Rs. 3105.45. The total number of shares traded during the day was 1983 in over 697 trades.

The stock hit an intraday high of Rs. 3160.00 and intraday low of 3095.00. The net turnover during the day was Rs. 6173843.00.

Source : Equity Bulls

Keywords

GlandPharma Q4FY22 FY2022 ResultUpdate